Lv1
8 积分 2025-06-04 加入
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
10天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1个月前
已完结
The therapeutic window of antibody drug conjugates: A dogma in need of revision
5个月前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
6个月前
已完结
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
6个月前
已完结
Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody
6个月前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
7个月前
已完结
Next-generation characterization of the Cancer Cell Line Encyclopedia
7个月前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
7个月前
已完结
CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase II
8个月前
已完结
皖公网安备34019202002308
